SCHEMBL2430231

SCHEMBL2430231

CCCC[Sn](CC#N)(CCCC)CCCC

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20658212 0.78 TSHR (0.33) TSHRALDH1A1LMNA
SCHEMBL7109247 0.77 TSHR (0.55) TSHRALDH1A1
Water SCHEMBL3700992 0.76 TSHR (0.43) TSHRALDH1A1LMNA
SCHEMBL1042228 0.74 SMN1; SMN2 (0.31) TSHRLMNA
SCHEMBL28438742 0.73 TSHR (0.46) TSHRALDH1A1LMNA
SCHEMBL135552 0.73 TSHR (0.46) TSHRALDH1A1LMNA
SCHEMBL8951503 0.72
SCHEMBL14914835 0.72 RAB9A (0.33) LMNA
Hydrochloric Acid SCHEMBL336735 0.70 TSHR (0.43) TSHRALDH1A1LMNA
SCHEMBL3577655 0.70 TSHR (0.43) TSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4655293-A1 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS Syngenta Crop Protection AG (CH) 2025-12-03 EP disclosed
WO-2024156664-A1 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA CROP PROTECTION AG (CH) 2024-08-02 WO disclosed
CN-117836301-A 2, 2-difluoro-5H- [1,3] dioxolo [4,5-F ] isoindol-7-one derivatives as pesticides 先正达农作物保护股份公司 2024-04-05 CN disclosed
CN-116075226-A Pesticidally active heterocyclic derivatives with sulfur containing substituents 先正达农作物保护股份公司 2023-05-05 CN disclosed
CN-116056577-A Pesticidally active heterocyclic derivatives with sulfur containing substituents 先正达农作物保护股份公司 2023-05-02 CN disclosed
CN-110526832-B Method for preparing polysubstituted alicyclic compound 浙江师范大学 2022-06-10 CN disclosed
CN-106715428-B Pesticidally active tetracyclic derivatives with sulfur-containing substituents 先正达参股股份有限公司 2020-07-07 CN disclosed
US-20200207741-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE HOFFMANN-LA ROCHE INC. 2020-07-02 US disclosed
US-10640491-B2 Inhibitors of bruton's tyrosine kinase HOFFMANN-LA ROCHE INC. (US) 2020-05-05 US disclosed
US-20200055850-A1 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2020-02-20 US disclosed
US-20050288270-A1 New aminopyridine derivatives and their use as pharmaceuticals PFIZER INC 2005-12-29 US disclosed
WO-2005115985-A1 AMINOPYRIDINE DERIVATIVES AS SELECTIVE DOPAMINE D3 AGONISTS PFIZER LIMITED (GB) 2005-12-08 WO disclosed
US-20050182144-A1 Novel vitamin D analogues GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2005-08-18 US disclosed
EP-1268396-B1 DIPHENYL ETHER COMPOUNDS USEFUL IN THERAPY PFIZER LTD (GB) 2005-07-20 EP disclosed
EP-1537065-A1 ANALOGUES OF VITAMIN D Galderma Research & Development, S.N.C. (FR) 2005-06-08 EP disclosed
WO-2004020379-A1 ANALOGUES OF VITAMIN D GALDERMA RESEARCH & DEVELOPMENT, SNC (FR) 2004-03-11 WO disclosed
EP-1268396-A1 DIPHENYL ETHER COMPOUNDS USEFUL IN THERAPY Pfizer Limited (GB) 2003-01-02 EP disclosed
US-6448293-B1 TREATMENT OR PREVENTION OF A DISORDER IN WHICH THE REGULATION OF MONOAMINE TRANSPORTER FUNCTION IS IMPLICATED, SUCH AS PREMATURE EJACULATION. PFIZER INC. 2002-09-10 US disclosed
US-20020052395-A1 Diphenyl ether compounds useful in therapy ANDREWS MARK DAVID (GB) 2002-05-02 US disclosed
WO-2001072687-A1 DIPHENYL ETHER COMPOUNDS USEFUL IN THERAPY PFIZER LIMITED (GB) 2001-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288270-A1 New aminopyridine derivatives and their use as pharmaceuticals DRD2, DRD1, DRD3 TSHR 2194/4885ALDH1A1 792/4885LMNA 4736/4885
US-20050182144-A1 Novel vitamin D analogues CYP24A1, CYP2R1, VDR TSHR 816/4885ALDH1A1 121/4885LMNA 3140/4885
US-20200055850-A1 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS DDT, ACHE, GSTM1 TSHR 510/4885ALDH1A1 535/4885LMNA 4562/4885
US-20020052395-A1 Diphenyl ether compounds useful in therapy CBR1, OGFR, CBR3 TSHR 112/4885ALDH1A1 2048/4885LMNA 3251/4885
US-20200207741-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE BTK, SYK, LYN TSHR 3659/4885ALDH1A1 3660/4885LMNA 3704/4885
US-10640491-B2 Inhibitors of bruton's tyrosine kinase BTK, SYK, LYN TSHR 3754/4885ALDH1A1 3869/4885LMNA 4187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.